Changes in cochlear blood flow due to intra-arterial infusions of angiotensin II (3-8) (angiotensin IV) in guinea pigs

Hearing Research

Volumn 119, Issue 1-2, 1998, Pages 61-68

  Coleman, John K M ^b   Lee, Janet I ^b   Miller, Josef M ^b   Nuttall, Alfred L ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Angiotensin; Blood flow; Cochlea; Guinea pig; Hearing; Microcirculation

Indexed keywords

ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II [3-8]; ANGIOTENSIN IV [1-5]; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; DIVALANAL ANGIOTENSIN II [3-8]; H 6965; RECEPTOR SUBTYPE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN ARTERY; COCHLEA BLOOD FLOW; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GUINEA PIG; INTRAARTERIAL DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; COCHLEA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUINEA PIGS; INFUSIONS, INTRA-ARTERIAL; LASER-DOPPLER FLOWMETRY; MALE; MOLECULAR SEQUENCE DATA; REGIONAL BLOOD FLOW;

EID: 0032080537     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(98)00038-0     Document Type: Article

References (33)

1. Braszko J.J., Kupryszewski G., Witczuk B., Wisniewski K. Angiotensin II-(3-8)-hexapeptide affects motor activity performance of passive avoidance and a conditioned avoidance response in rats. Neuroscience. 27:(3):1988;777-783.
2. Braszko J.J., Wlasienko W., Koziolkiewicz W.G., Janecka A., Wisniewski K. The 3-7 fragment of the angiotensin is probably responsible for its psychoactive properties. Brain Res. 542:1991;49-54.
3. 8-angiotensin II receptor binding in the cochlea SHR, WKY, and SD rat pups. Soc. Neurosci. (Abstr.). 16:(1):1990;873.
4. Coleman J.K.M., Krebs L.T., Lawrence K.A., Ong B., Sardinia M., Harding J., Wright J.W. Changes in renal blood flow due to infusions of angiotensin II(3-8) [AIV] in normotensive rats and distribution of these receptors in the rat kidney. FASEB J. (Abstr.). 7:(3, part 1):1993;A437.
5. 1 ANG IV and ANG IV's relationship to nitric oxide in the rat kidney. Exp. Biol. (Abstr.). 8:(4, part 1):1994;A582.
6. Ferrario, C.M., Brasnihan, K.B., Diz, D.I., Jaiswal, N., Khosla, M.C., Misted, A. and Tallant, E.A. (1991) Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension 18, III/126-III/133.
7. Haberl R.L., Decker P.J., Einhaupl K.M. Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ. Res. 68:1991;1621-1627.
8. Haberl R.L., Decker P.J., Piepgras A., Einhaupl K.M. Is L-arginine the precursor of an endothelium-derived relaxing factor in the cerebral microcirculation? Cardiovasc. Pharmacol. 17:(Suppl. 3):1991;S15-S18.
9. Hall K.L., Venkateswaran S., Hanesworth J.M., Schelling M., Harding J.W. Characterization of a functional AngiotensinIV receptor on coronary microvascular endothelial cells. Regul. Pept. 58:1995;107-115.
10. Harding J., Cook V.I., Miller-Wing A.V., Hanesworth J.M., Sardinia M.F., Hall K.L., Stobb J.W., Swanson G.N., Coleman J.K.M., Wright J.W., Harding E.C. Identification of an AII (3-8)[AIV] binding site in guinea pig hippocampus. Brain Res. 583:1992;340-343.
11. Hultcrantz E. Clinical treatment of vascular inner ear disease. Am. J. Otolaryngol. 9:1988;317-322.
12. Kerins D.M., Hao Q., Vaugn D.E. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J. Clin. Invest. 96:1995;2515-2520.
13. Kono T., Ikeda F., Taniguchi A., Imura H., Oseko F., Yoshioka M., Khosla M. Responses of patients with Batters syndrome to angiotensin III and angiotensin-II-(3-8)-hexapeptide. Acta Endocrinol. (Copenh.). 109:1985;249-253.
14. 1 in the rat. Soc. Neurosci. Abstr. 21:(part 1):1995;156.
15. McLaren G.M., Coleman J.K.M., Quirk W.S., Dengerink H.A., Wright J.W. Influences of intra-arterial infusion of arginine vasopressin on cochlear blood flow in the rat. Hear. Res. 55:1991;1-8.
16. McLaren G.M., Quirk W.S., Laurikainen E., Coleman J.K.M., Seidman M.D., Dengerink H.A., Nuttall A.L., Miller J.M., Wright J.W. Substance p increases cochlear blood flow without changing cochlear electrophysiology. Hear. Res. 71:1993;183-189.
17. Miller J.M., Dengerink H. Control of inner ear blood flow. Am. J. Otolaryngol. 9:1988;302-316.
18. Miller, J.M. and Nuttall, A.L. (1990) Cochlear blood flow. In: Shepard, A.P. and Oberg, P.A. (Eds.), Laser Doppler Flowmetry. Kluwer Academic Press, Norwell, MA, pp. 319-348.
19. Moller I., Chai S.Y., Oldfield B.J., Mckinley M.J., Casely D., Mendelsohn F.A.O. Localization of angiotensin IV binding sites to motor and sensory neurons in the sheep spinal cord. Brain Res. 701:1995;301-306.
20. 4 receptors in the Macaca fascicularis brain. Brain Res. 712:1996;307-324.
21. Moller I., Small D.H., Reed G., Harding J.W., Mendelsohn F.A.O., Chai S.Y. Angiotensin IV inhibits neurite outgrowth in cultured embryonic chicken sympathetic neurones. Brain Res. 725:1996;61-66.
22. Quirk W.S., Dengerink H.A., Coleman J.K.M., Wright J.W. Autoregulation in Wistor-Kyoto rats. Hear. Res. 41:1989;53-60.
23. Quirk W.S., Coleman J.K.M., Hanesworth J., Harding J.W., Wright J.W. Noise-induced elevations of plasma endothelin (ET-3). Hear. Res. 80:(1):1994;119-122.
24. Ren T-Y., Nuttall A.L., Miller J.M. Contribution of the anterior inferior cerebellar artery to cochlear blood flow in the guinea pig. Hear. Res. 71:1993;91-97.
25. Sardinia M.F., Hanesworth J.M., Krebs L.T., Harding J.W. AT4 receptor binding characteristics: D-amino acid and glycine substituted peptides. Peptides. 14:1993;949-954.
26. Sardinia M.F., Hanesworth J.M., Krishan F., Harding J.W. AT4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues. Peptides. 15:1994;1399-1406.
27. Semple P.F., Boyd A.S., Dawes P.M., Morton J. Angiotensin II and its heptapeptide (2-8), hexapeptide (3-8) and pentapeptide (4-8) metabolites in arterial venous blood of man. Circ. Res. 39:(5):1976;671-678.
28. Swanson G., Hanesworth J.M., Sardinia M., Coleman J.K.M., Wright J.W., Hall K.L., Miller-Wing A.V., Stobb J.W., Cook V.I., Harding E.C., Wright J.W. Discovery of a distinct binding site for angiotensin II (3-8), putative angiotensin IV. Regul. Pept. 40:1992;409-419.
29. Vass Z., Nuttall A.L., Coleman J.K.M., Miller J.M. Capsaicin-induced release of substance p increases cochlear blood flow in the guinea pig. Hear. Res. 89:1995;86-92.
30. Wada J., Paloheimo I., Thalmann B., Bohne A., Thalmann R. Maintenance of cochlear function with artificial oxygen carriers. Laryngoscope. 89:1979;1457-1473.
31. Wright J.W., Jenson L.L., Roberts K.A., Sardinia M.F., Harding J.W. Structure function analysis of brain angiotensin control of pressor action in rats. Am. J. Physiol. 257:(Reg. Integr. Comp. Physiol.):1989;R1551-R1557.
32. Wright J.W., Harding J.W. Brain receptors subtypes in the control of physiological and behavioral responses. Neurosci. Biobehav. Rev. 18:(1):1994;21-53.
33. Wright J.W., Krebs L., Stobb J., Harding J.W. The angiotensin IV system: Functional implications. Front. Neuroendocrinol. 16:1994;23-52.